Patterns and predictors of cigarette smoking among HIV-infected patients in northern Nigeria

International Journal of STD and AIDS

Volumn 23, Issue 12, 2012, Pages 849-852

  Iliyasu, Z ^a   Gajida, A U ^a   Abubakar, I S ^a   Shittu, O ^a   Babashani, M ^a   Aliyu, M H ^b  

^a AMINU KANO TEACHING HOSPITAL   (Nigeria)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Cardiovascular risk; Cigarette smoking; HIV AIDS; Men; Nigeria

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICA SOUTH OF THE SAHARA; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EDUCATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NIGERIA; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION PROGRAM; TERTIARY HEALTH CARE;

ADULT; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NIGERIA; ODDS RATIO; PREVALENCE; SMOKING;

EID: 84871709744     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2012.012001     Document Type: Article

References (23)

1. Report on the Global HIV/AIDS Epidemic. Geneva: Joint United Nations Programme on HIV/AIDS 2010:45-9
2. WHO. Guidelines for controlling and monitoring the tobacco epidemic. Geneva: WHO 2010:33-6
3. Crothers K, Goulet JL, Rodriguez-Barradas MC, et al. Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans. AIDS Educ Prev 2009;21(Suppl.):40-53
4. Palella FJ, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006;43:27-34
5. Kohli R, Lo Y, Homel P, et al. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. Clin Infect Dis 2006;43:90-8
6. Miguez-Burbano MJ, Burbano X, Ashkin D, et al. Impact of tobacco use on the development of opportunistic respiratory infections in HIV seropositive patients on antiretroviral therapy. Addict Biol 2003;8:39-43
7. The DAD Study Group. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007;356:1723-35
8. van Zyl Smit RN, Pai M, Yew WW, et al. Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD. Eur Respir J 2010;35:27-33
9. Desalu OO, Oluboyo PO, Olokoba AB, et al. Prevalence and Determinants of Tobacco smoking among HIV patients in North East Nigeria. Afr J Med Med Sci 2009;38:103-8
10. Jaquet A, Ekouevi D, Aboubakrine M, et al. Tobacco use and its determinants in HIV-infected patients on antiretroviral therapy in West Africa countries. Int. J Tuberc Lung Dis 2009;13:1433-9
11. Lwanga S, Lemeshow S. Sample size determination in health studies: a practical manual, Geneva: World Health Organization, 1991:23-41
12. SPSS for Windows, Rel. 16.0.1. 2007. Chicago: SPSS Inc.
13. Desalu OO, Olokoba AB, Danburam A, Salawu FK, Issa BM. Epidemiology of tobacco smoking among adult population in north east Nigeria. Internet J Epidemiol 2008;6:23-7
14. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005;97:425-32
15. Cooperman NA, Schoenbaum E, Klein R, Arnsten JH. Cigarette smoking among older men and women with or at-risk for HIV infection. Poster presented at the Society for Research on Nicotine and Tobacco 13th Annual Meeting. Austin, TX: Society for Research on Nicotine and Tobacco, 2007
16. Duval X, Baron G, Garelik D, et al. and the EVIT study Group. Living with HIV, antiretroviral treatment experience and tobacco smoking: results from a multisite cross-sectional study. Antivir Ther 2008;13:389-97
17. US Public Health Service Report. A clinical practice guideline for treating tobacco use and dependence. JAMA 2000;283:3244-54
18. Shapiro AE, Tshabangu N, Golub JE, Martinson NA. Intention to quit smoking among human immunodeficiency virus infected adults in Johannesburg, South Africa. Int J Tuberc Lung Dis 2011;15:140-2
19. Huber M, Ledergerber B, Sauter R, et al. Swiss HIV Cohort Study Group. Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians. HIV Med 2012;13:387-97
20. Vidrine DJ. Cigarette smoking and HIV/AIDS: health implications, smoker characteristics and cessation strategies. AIDS Educ Prev 2009; 21:3-13
21. Cummins D, Trotter G, Moussa M, Turham G. Smoking cessation for clients who are HIV-positive. Nurs Stand 2005;20:41-7. PubMed PMID: 16350501
22. Elzi L, Spoerl D, Voggensperger J, et al. Swiss HIV Cohort Study. A smoking cessation programme in HIV-infected individuals: a pilot study. Antivir Ther. 2006;11:787-95. PubMed PMID: 17310823
23. Vidrine DJ, Arduino RC, Lazev AB, Gritz ER. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS 2006;20:253-60. PubMed PMID: 16511419